CORC

在结果中检索

CORC

浏览/检索结果: 共572条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 期刊论文
AUTOPHAGY, 2021, 卷号: 17
作者:  Klionsky, Daniel J.;  Abdel-Aziz, Amal Kamal;  Abdelfatah, Sara;  Abdellatif, Mahmoud;  Abdoli, Asghar
收藏  |  浏览/下载：267/0  |  提交时间：2021/05/31
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：57/0  |  提交时间：2019/12/05
Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial 期刊论文
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 卷号: 4, 期号: 2
作者:  Li, Jun;  Jia, Jidong;  Hou, Jin Lin;  Mohamed, Rosmawati;  Duan, Zhongping
收藏  |  浏览/下载：44/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
Mussel-inspired Fe 3 O 4 @Polydopamine(PDA)-MoS 2 core–shell nanosphere as a promising adsorbent for removal of Pb 2+ from water 期刊论文
Journal of Molecular Liquids, 2019, 卷号: 282, 页码: 598-605
作者:  Wang, Qingmiao;  Peng, Lai*;  Gong, Yuanyu;  Jia, Feifei;  Song, Shaoxian
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/04
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Mussel-inspired Fe3O4@Polydopamine(PDA)-MoS2 core–shell nanosphere as a promising adsorbent for removal of Pb2+ from water 期刊论文
Journal of Molecular Liquids, 2019, 卷号: 282
作者:  Wang, Qingmiao;  Peng, Lai;  Gong, Yuanyu;  Jia, Feifei;  Song, Shaoxian
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace